Shukra Pharmaceuticals Rights Issue will open for subscription from 15 February 2023. the company aims for an issue size of ₹18.79 Crores through this rights Issue.
About the company
Shukra Pharmaceuticals Limited is engaged in the field of Pharmaceuticals. They started their operations with a fully integrated plant in Rakanpor in Kalol, Gandhinagar – Gujarat. Even since its incorporation, the company has grown to immense heights in terms of operations and has expanded largely. Today, they have an internationally accredited Laboratory in Ahmedabad for creating each product on the highest quality standards.
Shukra Pharmaceuticals undertake operations including-
- Contract Manufacturing
- Loan License
- Domestic and International Operations
The team of research analysts, medical officers, and technical experts of Shukra Pharmaceuticals ensure quality in each product and follow stringent regulations to deliver the same.
Objectives of the Issue
- To augment the existing and incremental working capital requirement of the company,
- General Corporate Purposes.
Rights Issue Timetable
| Record Date | 02 February 2023 |
| Credit of Rights Entitlements | 13 February 2023 |
| Bid/Offer Opens On | 15 February 2023 |
| Renunciation of Rights Entitlements | 23 February 2023 |
| Bid/Offer Closes On | 28 February 2023 |
| Deemed Date of Allotment | 08 March 2023 |
| Credit Date | 14 March 2023 |
| Listing Date | 15 March 2023 |
Shukra Pharmaceuticals Rights Issue Details
| Issue Open | Feb 15, 2023 – Feb 28, 2023 |
| Security Name | Shukra Pharmaceuticals Limited |
| Issue Size (Shares) | 9,394,050 |
| Issue Size (Amount) | ₹18.79 Crores |
| Issue Price | ₹20 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined. |
| Entitlement | 6 Equity Shares for every 1 Fully Paid Equity Share held |
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth |
|---|---|---|---|---|
| 31-Mar-21 | 35.61 | 11.55 | 0.19 | 15.60 |
| 31-Mar-22 | 35.11 | 20.57 | 0.75 | 16.35 |
Rights Issue Documents
Lead Manager(s)
- ————-
Rights Issue Registrar
Purva Sharegistry India Pvt Ltd
Phone: +91-022-23018261/ 23016761
Email: support@purvashare.com
Website: http://www.purvashare.com
Company Contact Information
Shukra Pharmaceuticals Limited
Veer House, 3rd Floor, Judges Bungalow Road,
Opp. WIAA Motor Training School,
Bodakdev, Ahmedabad- 380054
Phone: +91 79 48901030
Email: info@shukrapharmaceuticals.com
Website: http://www.shukrapharmaceuticals.com/#
Final Thoughts
Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.
Happy investing
